Hao Zhang

Title: Hao Zhang: Innovator in Pharmaceutical Synthesis

Introduction

Hao Zhang is a notable inventor based in Wujiang, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly through his innovative work on azaphenalene-3-one derivatives. His research focuses on developing compounds that have the potential to enhance anti-tumor drug efficacy.

Latest Patents

Hao Zhang holds a patent for an azaphenalene-3-one derivative, which includes a preparation method and its applications. This derivative is characterized by a specific formula where R can be various chemical groups, including H, 2-fluoroethylamino, and several others. The preparation method is noted for its simplicity, high yield, and ease of post-treatment, resulting in a high purity product. Importantly, this derivative exhibits significant inhibitory activity against the PARP enzyme, laying the groundwork for the development of improved anti-tumor drugs utilizing PARP inhibitors.

Career Highlights

Hao Zhang is currently employed at Suzhou Kangrun Pharmaceuticals Inc., where he continues to advance his research in pharmaceutical innovations. His work is pivotal in the ongoing quest for effective cancer treatments.

Collaborations

Hao Zhang collaborates with esteemed colleagues, including Xiaodong Wang and Weiliang Xu, who contribute to his research endeavors.

Conclusion

Hao Zhang's contributions to pharmaceutical synthesis and his innovative patent on azaphenalene-3-one derivatives highlight his role as a key figure in the development of potential anti-tumor therapies. His work exemplifies the intersection of chemistry and medicine, paving the way for future advancements in cancer treatment.